Press release
Ovarian Cancer Diagnostics Market Growth, Size, Share, Trends, Key Drivers And Opportunities Report 2024
Ovarian Cancer Diagnostics Market
The Business Research Company offers in-depth market insights through Ovarian Cancer Diagnostics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ovarian cancer diagnostics market size has grown strongly in recent years. It will grow from $2.62 billion in 2023 to $2.82 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in biomarker discovery and validation, transvaginal ultrasound adoption, brca gene mutations awareness, research on tumor markers, screening programs and guidelines.
The ovarian cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to early detection initiatives, increasing incidence of ovarian cancer, integration of artificial intelligence (ai), personalized medicine approaches, emergence of novel biomarkers, genomic and proteomic profiling. Major trends in the forecast period include biosensor technologies for early detection, digital pathology integration, innovations in imaging modalities, improved imaging technologies, advancements in pathology techniques.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12022&type=smp
Market Segmentation:
The ovarian cancer diagnostics market covered in this report is segmented -
1) By Product Type: Instruments, Kits, Reagents
2) By Diagnosis Type: Biopsy, Blood Test, Imaging, Other Diagnosis Types
3) By Cancer Type: Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types
4) By End User: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes
Major Driver - Rising Prevalence Of Ovarian Cancer To Drive Market Growth
The rise in the prevalence of ovarian cancer is expected to propel the growth of the ovarian cancer diagnostics market going forward. Ovarian cancer is a malignant tumor that develops in the ovaries, the female reproductive organs responsible for producing eggs and hormones. This shift has resulted from increased longevity, delayed childbearing, and lifestyle changes. Ovarian cancer diagnostics can help reduce the prevalence of ovarian cancer by enabling early detection and intervention, leading to timely treatment and improved outcomes. For instance, in February 2022, according to the World Ovarian Cancer Coalition, a Canada-based not-for-profit organization, ovarian cancer affected 313,959 women worldwide in 2020. This will have increased by 42% by 2040 to 445,721; between 2020 and 2040, there will be a 51% increase in the number of women dying from ovarian cancer, from 207,252 to 313,617. Therefore, the rising prevalence of ovarian cancer is driving the growth of the ovarian cancer diagnosis market.
Competitive Landscape:
Major companies operating in the ovarian cancer diagnostics market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Bio-rad Laboratories Inc., Qiagen N.V., Natera Inc., The American Cancer Society, Myriad Genetics Inc., ArcherDX Inc., Invitae Corporation, Guardant Health, Luminex Corporation, NanoString Technologies Inc., Siemens Healthcare Private Limited, Menarini Silicon Biosystems S.p.A., Precipio Inc., Angle plc
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report
Top Trend - Innovative Diagnostic Technologies Transforming The Market
Advanced diagnostic technology is a key trend gaining popularity in the ovarian cancer diagnostics market. Companies operating in the ovarian cancer diagnostic market are adopting advanced diagnostic technologies to sustain their position in the market. For instance, in November 2022, Hoffmann-La Roche AG, a Switzerland-based pharmaceutical and healthcare company, received FDA approval for the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, the first (immunohistochemistry) IHC-based companion diagnostic test kit for the identification of ovarian cancer patients eligible for ELAHERE, which is a prescription medication for ovarian cancer. This test is specifically designed to get critical insights and obtain detailed clinical information about the ovarian cancer condition, which helps deliver improved disease management and patient outcomes.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ovarian Cancer Diagnostics Market Characteristics
3. Ovarian Cancer Diagnostics Market Trends And Strategies
4. Ovarian Cancer Diagnostics Market - Macro Economic Scenario
5. Ovarian Cancer Diagnostics Market Size And Growth
…..
27. Ovarian Cancer Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Diagnostics Market Growth, Size, Share, Trends, Key Drivers And Opportunities Report 2024 here
News-ID: 3428917 • Views: …
More Releases from The Business research company
Rail Transit Protective Coating Market Overview: Major Segments, Strategic Devel …
The rail transit protective coating sector is positioned for significant expansion in the coming years, driven by technological advancements and increasing infrastructure investments. This market is evolving rapidly as stakeholders prioritize durability, sustainability, and efficiency in rail transit systems. Let's explore the market's valuation projections, leading companies, emerging trends, and detailed segment analysis to get a clearer understanding of its future trajectory.
Expected Market Size and Growth Outlook for Rail Transit…
Analysis of Segments and Major Growth Areas in the Product Implementation Servic …
The product implementation services sector is on the verge of significant expansion, driven by evolving technology needs and increasing enterprise adoption of sophisticated systems. Understanding the current market size, key contributors, emerging trends, and segment breakdowns offers valuable insights into what lies ahead for this dynamic industry.
Market Size and Expected Growth Trajectory in the Product Implementation Services Market
The product implementation services market is projected to experience strong growth…
Key Strategic Developments and Emerging Changes Shaping the Polyvinylidene Fluor …
The polyvinylidene fluoride (PVDF) resin market is on track for significant expansion over the coming years. Driven by various technological advances and rising demands across multiple industries, this sector is expected to evolve rapidly. Let's explore the anticipated market growth, influential players, key trends, and detailed segmentation shaping the future of PVDF resin.
Projected Growth and Market Size of the Polyvinylidene Fluoride Resin Market
The PVDF resin market is forecasted…
Leading Companies Fueling Innovation and Growth in the Partyline Intercom System …
The partyline intercom systems market is gearing up for significant expansion as communication needs evolve across various industries. With increasing demand for more versatile and efficient communication tools, this sector is set to witness rapid advancements and growing adoption over the coming years. Let's explore the market size projections, key drivers, major players, emerging trends, and important segments shaping this dynamic industry.
Projected Market Size and Growth Trajectory of the Partyline…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
